Exicure Stock (NASDAQ: XCUR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 10.00 / 303.26K |
Day Range | - - - |
52 Wk Range | 0.30 - 1.47 |
Market Cap | $2.77M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 2.95% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Exicure (NASDAQ:XCUR) through any online brokerage.
Other companies in Exicure’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO) and Quoin Pharmaceuticals (NASDAQ:QNRX).
There is no analysis for Exicure.
Exicure has a consensus price target of $2.00.
The stock price for Exicure (NASDAQ: XCUR) is $0.32 last updated July 3, 2024 at 1:36 AM EDT.
There are no upcoming dividends for Exicure.
Exicure’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Exicure.
Exicure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.